Th17-stimulating Protein Vaccines Confer Protection againstPseudomonas aeruginosaPneumonia

IL-17 Is a Critical Component of Vaccine-Induced Protection against Lung Infection by Lipopolysaccharide-Heterologous Strains of Pseudomonas aeruginosa

(2014) G. P. Priebe et al.   JOURNAL OF IMMUNOLOGY

The Th17 Pathway in Cystic Fibrosis Lung Disease

(2011) Hui-Leng Tan et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

TH17-Based Vaccine Design for Prevention of Streptococcus pneumoniae Colonization

(2011) Kristin L. Moffitt et al.   Cell Host & Microbe

Pneumonia Due to Pseudomonas aeruginosa

(2011) Hsin-Yun Sun et al.   CHEST

Th17 Cells Mediate Clade-Specific, Serotype-Independent Mucosal Immunity

(2011) Kong Chen et al.   IMMUNITY

Qualitative Evaluation of Adjuvant Activities and Its Application to Th2/17 Diseases

(2011) Sho Matsushita et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Polimorfismo de los genes mucA y fpvA en Pseudomonas aeruginosa de pacientes con fibrosis quística: coexistencia de variantes genéticas en el mismo paciente

(2010) María José Pozuelo et al.   ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA

Early production of IL-17 protects against acute pulmonaryPseudomonas aeruginosainfection in mice

(2010) Jialin Liu et al.   FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY

Reverse Vaccinology: Developing Vaccines in the Era of Genomics

(2010) Alessandro Sette et al.   IMMUNITY

Utility of In Vivo Transcription Profiling for Identifying Pseudomonas aeruginosa Genes Needed for Gastrointestinal Colonization and Dissemination

(2010) Andrew Y. Koh et al.   PLoS One

Role of Pseudomonas aeruginosa type III effectors in disease

(2009) Joanne Engel et al.   CURRENT OPINION IN MICROBIOLOGY

Genome-Wide Study of Pseudomonas aeruginosa Outer Membrane Protein Immunogenicity Using Self-Assembling Protein Microarrays

(2009) W. R. Montor et al.   INFECTION AND IMMUNITY

A Fusion Protein Vaccine Containing OprF Epitope 8, OprI, and Type A and B Flagellins Promotes Enhanced Clearance of Nonmucoid Pseudomonas aeruginosa

(2009) E. T. Weimer et al.   INFECTION AND IMMUNITY

Proteomic Identification of OprL as a Seromarker for Initial Diagnosis of Pseudomonas aeruginosa Infection of Patients with Cystic Fibrosis

(2009) A. R. Rao et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Intranasal Immunization Promotes Th17 Immune Responses

(2009) B. M. Zygmunt et al.   JOURNAL OF IMMUNOLOGY

SecB—A chaperone dedicated to protein translocation

(2009) Philipp Bechtluft et al.   Molecular BioSystems

The type III secretion system of Pseudomonas aeruginosa: infection by injection

(2009) Alan R. Hauser   NATURE REVIEWS MICROBIOLOGY

Pseudomonas aeruginosa Population Structure Revisited

(2009) Jean-Paul Pirnay et al.   PLoS One

The Approach toPseudomonas aeruginosain Cystic Fibrosis

(2009) Glenda Bendiak et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Bacterial Genome Variability and Its Impact on Vaccine Design

(2008) John L. Telford   Cell Host & Microbe

Simian immunodeficiency virus–induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut

(2008) Manuela Raffatellu et al.   NATURE MEDICINE

Interleukin-17A Mediates Acquired Immunity to Pneumococcal Colonization

(2008) Ying-Jie Lu et al.   PLoS Pathogens

Sec- and Tat-mediated protein secretion across the bacterial cytoplasmic membrane—Distinct translocases and mechanisms

(2007) Paolo Natale et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES